Dr. Navid Khan brings more than 20 years of experience across Medical Affairs, R&D, and Commercial functions, with deep expertise in neurology, immunology, and rare diseases. Prior to joining Vor Bio, Dr. Khan served as Head of the Neuromuscular Therapeutic Area in Medical Affairs at argenx, leading four major product launches of efgartigimod (VYVGART & […]
Team Role: Leadership
Carol Lincoln, CCP
Carol Lincoln brings more than 25 years of experience leading human resources strategy, total rewards, and operations across the biotechnology, pharmaceutical, financial services, and publishing industries. She joins Vor Bio from iTeos Therapeutics, where she most recently served as Head of Total Rewards and U.S. Human Resources. In that role, she led the creation and […]
Jeremy Sokolove, MD
Dr. Sokolove brings more than 18 years of experience leading clinical development and translational research in autoimmune and inflammatory diseases across biotechnology and pharmaceutical organizations. Prior to joining Vor Bio, Dr. Sokolove was Chief Medical Officer In-Residence at Roivant Sciences, where he led strategic assessment and in-licensing of novel therapeutic programs and provided clinical and […]
Adi Osovsky, SJD
Dr. Osovsky brings nearly two decades of corporate counsel and law firm experience in the biotechnology and pharmaceutical sectors. She joins Vor Bio from iTeos Therapeutics, where she served as Executive Vice President, Head of Legal & Corporate Secretary. In that role, she led the company’s corporate legal and compliance activities and oversaw information technology. […]
Dallan Murray
Mr. Murray brings more than 25 years of experience leading commercial strategy, global product launches, and customer-facing organizations in biotechnology and pharmaceutical companies. He joins Vor Bio from Sarepta Therapeutics, where he most recently served as Executive Vice President, Chief Customer Officer. In that role, he led the commercial and medical affairs organizations, along with […]
Sandy Mahatme
Mr. Mahatme joins Vor Bio with more than 30 years of executive leadership experience in the biopharmaceutical industry, with a strong track record in capital markets, business development, global operations, and shareholder value creation. He most recently served as President, Chief Operating Officer, and Chief Financial Officer of National Resilience, Inc., a biomanufacturing company he […]
Jean-Paul Kress, MD
Dr. Kress brings decades of executive leadership experience in the pharmaceutical and biotech industries. He most recently served as Chief Executive Officer of MorphoSys, where he led the development, approval and commercialization of Monjuvi® (tafasitamab), and advanced the company’s pipeline through the landmark acquisition of Constellation Pharmaceuticals in 2021, strengthening MorphoSys’ position in oncology innovation […]